Log on / register
Feedback | Support | My details

Pre-publication history

Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations

Florian Then Bergh* email, Tania Kümpfel* email, Erina Schumann email, Ulrike Held email, Michaela Schwan email, Mirjana Blazevic email, Axel Wismüller email, Florian Holsboer email, Alexander Yassouridis email, Manfred Uhr email, Frank Weber email, Martin Daumer email, Claudia Trenkwalder email and Dorothee P Auer email

BMC Neurology 2006, 6:19doi:10.1186/1471-2377-6-19

Pre-publication versions of this article and reviewers' reports

Original submission - Version 1Manuscript30 Jan 2006
Reviewer's ReportMarino Zorzon13 Feb 2006
Reviewer's Reporthans-peter hartung09 Mar 2006
Resubmission - Version 2ManuscriptAuthors' comments27 Apr 2006
Reviewer's Reporthans-peter hartung02 May 2006
Reviewer's ReportMarino Zorzon10 May 2006
Resubmission - Version 3Manuscript17 May 2006
Resubmission - Version 4Manuscript18 May 2006
Resubmission - Version 5Manuscript23 May 2006
Accepted23 May 2006
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2008 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.